Article in Proceedings of the National Academy of Sciences illustrates use of SILCS mapping technology to improve treatments for asthma and chronic obstructive pulmonary disease December 14, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced its Co-Founder and Chief Scientific Officer, Alexander [...]

Position: Scientist – Medicinal Chemistry and Computational Design What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We are the management team, the operators, and the entrepreneurs. We do not write checks and just pop in for board meetings. We show up to our labs, our production facilities, and [...]

SilcsBio and Helix BioStructures to tap mutual areas of expertise in drug design to spur new drug design opportunities for pharmaceutical and research organizations August 29, 2022, Baltimore, MD and Indianapolis, IN – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the launch of a partnership [...]

Dash to bring pharmacology background to drive product development and design services for SilcsBio July 8, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of RC Dash, an accomplished pharmacologist with significant research experience in drug design, as Applications Scientist. [...]

Kognole background as a computational chemist and a biophysicist to fuel product development and client services for SilcsBio June 8, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of Abhishek Kognole, PhD, a computational chemist and a biophysicist, as Applications [...]